EP1126792A1 - Antimikrobische zusammensetzungen zum beschüutzen von haut und zahngewebe - Google Patents
Antimikrobische zusammensetzungen zum beschüutzen von haut und zahngewebeInfo
- Publication number
- EP1126792A1 EP1126792A1 EP99961586A EP99961586A EP1126792A1 EP 1126792 A1 EP1126792 A1 EP 1126792A1 EP 99961586 A EP99961586 A EP 99961586A EP 99961586 A EP99961586 A EP 99961586A EP 1126792 A1 EP1126792 A1 EP 1126792A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dental
- composition
- agent
- solvent
- microbial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 130
- 230000000845 anti-microbial effect Effects 0.000 title description 27
- 239000004599 antimicrobial Substances 0.000 claims abstract description 70
- 239000002904 solvent Substances 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 26
- 230000000813 microbial effect Effects 0.000 claims abstract description 13
- 239000000758 substrate Substances 0.000 claims abstract description 11
- 230000002401 inhibitory effect Effects 0.000 claims abstract 2
- 239000003795 chemical substances by application Substances 0.000 claims description 25
- 239000007767 bonding agent Substances 0.000 claims description 16
- 239000003479 dental cement Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical group OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 11
- 229960003500 triclosan Drugs 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 125000002091 cationic group Chemical group 0.000 claims description 9
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical group CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 claims description 6
- 230000000202 analgesic effect Effects 0.000 claims description 6
- -1 benzoic ester Chemical class 0.000 claims description 6
- 150000001282 organosilanes Chemical group 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 4
- AMFGWXWBFGVCKG-UHFFFAOYSA-N Panavia opaque Chemical compound C1=CC(OCC(O)COC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCC(O)COC(=O)C(C)=C)C=C1 AMFGWXWBFGVCKG-UHFFFAOYSA-N 0.000 claims description 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 4
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical group C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims description 4
- 230000037452 priming Effects 0.000 claims description 4
- HSFXEOPJXMFQHG-ARJAWSKDSA-N (z)-4-[2-(2-methylprop-2-enoyloxy)ethoxy]-4-oxobut-2-enoic acid Chemical compound CC(=C)C(=O)OCCOC(=O)\C=C/C(O)=O HSFXEOPJXMFQHG-ARJAWSKDSA-N 0.000 claims description 3
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 claims description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- MKVYSRNJLWTVIK-UHFFFAOYSA-N ethyl carbamate;2-methylprop-2-enoic acid Chemical compound CCOC(N)=O.CC(=C)C(O)=O.CC(=C)C(O)=O MKVYSRNJLWTVIK-UHFFFAOYSA-N 0.000 claims description 3
- 150000002989 phenols Chemical group 0.000 claims description 3
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical group CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 claims description 2
- 150000001299 aldehydes Chemical class 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 claims description 2
- 229920005646 polycarboxylate Polymers 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical group OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 12
- 210000004872 soft tissue Anatomy 0.000 abstract description 5
- 210000004905 finger nail Anatomy 0.000 abstract 1
- 210000004906 toe nail Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 11
- 244000005700 microbiome Species 0.000 description 11
- 239000000853 adhesive Substances 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 210000003298 dental enamel Anatomy 0.000 description 8
- 210000004268 dentin Anatomy 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229960003260 chlorhexidine Drugs 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 238000005530 etching Methods 0.000 description 3
- VYKKDKFTDMVOBU-UHFFFAOYSA-N flusalan Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=CC(C(F)(F)F)=C1 VYKKDKFTDMVOBU-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- HTWRFCRQSLVESJ-UHFFFAOYSA-N 3-(2-methylprop-2-enoyloxy)propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCOC(=O)C(C)=C HTWRFCRQSLVESJ-UHFFFAOYSA-N 0.000 description 2
- ZAJCJTYYSXOWAY-UHFFFAOYSA-N 5-hydroxy-6-[4-[2-[4-(2-hydroxy-5-methyl-4-oxohex-5-enoxy)phenyl]propan-2-yl]phenoxy]-2-methylhex-1-en-3-one Chemical compound C1=CC(OCC(O)CC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCC(O)CC(=O)C(C)=C)C=C1 ZAJCJTYYSXOWAY-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 239000002318 adhesion promoter Substances 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical class C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 210000004262 dental pulp cavity Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000006150 trypticase soy agar Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 1
- DAVVKEZTUOGEAK-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethyl 2-methylprop-2-enoate Chemical compound COCCOCCOC(=O)C(C)=C DAVVKEZTUOGEAK-UHFFFAOYSA-N 0.000 description 1
- ZWXGXTQKWNNDKP-UHFFFAOYSA-N 2-(2-methylanilino)acetic acid oxiran-2-ylmethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1CO1.CC1=CC=CC=C1NCC(O)=O ZWXGXTQKWNNDKP-UHFFFAOYSA-N 0.000 description 1
- ZTJNPDLOIVDEEL-UHFFFAOYSA-N 2-acetyloxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC(C)=O ZTJNPDLOIVDEEL-UHFFFAOYSA-N 0.000 description 1
- SFPNZPQIIAJXGL-UHFFFAOYSA-N 2-ethoxyethyl 2-methylprop-2-enoate Chemical compound CCOCCOC(=O)C(C)=C SFPNZPQIIAJXGL-UHFFFAOYSA-N 0.000 description 1
- UOWIFEANNONTKY-UHFFFAOYSA-N 2-hydroxy-5-octanoyl-n-[3-(trifluoromethyl)phenyl]benzamide Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)=C1 UOWIFEANNONTKY-UHFFFAOYSA-N 0.000 description 1
- IEVADDDOVGMCSI-UHFFFAOYSA-N 2-hydroxybutyl 2-methylprop-2-enoate Chemical compound CCC(O)COC(=O)C(C)=C IEVADDDOVGMCSI-UHFFFAOYSA-N 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 description 1
- QALJHHQKMLSUME-UHFFFAOYSA-N 3,5,5-trichloro-n-(3-chlorophenyl)-6-hydroxycyclohexa-1,3-diene-1-carboxamide Chemical compound ClC1=CC(Cl)(Cl)C(O)C(C(=O)NC=2C=C(Cl)C=CC=2)=C1 QALJHHQKMLSUME-UHFFFAOYSA-N 0.000 description 1
- YJESMCOKCBFYBX-UHFFFAOYSA-N 3,5,6-trichloro-n-(3-chlorophenyl)-6-hydroxycyclohexa-2,4-diene-1-carboxamide Chemical compound C1=C(Cl)C=C(Cl)C(O)(Cl)C1C(=O)NC1=CC=CC(Cl)=C1 YJESMCOKCBFYBX-UHFFFAOYSA-N 0.000 description 1
- FLYZSJGIJYEAFV-UHFFFAOYSA-N 3,5-dibromo-2-hydroxy-n-[4-(trifluoromethyl)phenyl]benzamide Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=C(C(F)(F)F)C=C1 FLYZSJGIJYEAFV-UHFFFAOYSA-N 0.000 description 1
- USFZGCVGLNMJPL-UHFFFAOYSA-N 3,5-dichloro-n-(4-chlorophenyl)-2-hydroxybenzamide Chemical compound OC1=C(Cl)C=C(Cl)C=C1C(=O)NC1=CC=C(Cl)C=C1 USFZGCVGLNMJPL-UHFFFAOYSA-N 0.000 description 1
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- XOJWAAUYNWGQAU-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCOC(=O)C(C)=C XOJWAAUYNWGQAU-UHFFFAOYSA-N 0.000 description 1
- ZHSKUOZOLHMKEA-UHFFFAOYSA-N 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydron;chloride Chemical compound Cl.ClCCN(CCCl)C1=CC=C2N(C)C(CCCC(O)=O)=NC2=C1 ZHSKUOZOLHMKEA-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- CTFFKFYWSOSIAA-UHFFFAOYSA-N 5-bromo-n-(4-bromophenyl)-2-hydroxybenzamide Chemical compound OC1=CC=C(Br)C=C1C(=O)NC1=CC=C(Br)C=C1 CTFFKFYWSOSIAA-UHFFFAOYSA-N 0.000 description 1
- SAPGBCWOQLHKKZ-UHFFFAOYSA-N 6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCOC(=O)C(C)=C SAPGBCWOQLHKKZ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- LCXXNKZQVOXMEH-UHFFFAOYSA-N Tetrahydrofurfuryl methacrylate Chemical compound CC(=C)C(=O)OCC1CCCO1 LCXXNKZQVOXMEH-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 150000004287 bisbiguanides Chemical class 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229950004696 flusalan Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000000864 peroxy group Chemical group O(O*)* 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920005996 polystyrene-poly(ethylene-butylene)-polystyrene Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BOQSSGDQNWEFSX-UHFFFAOYSA-N propan-2-yl 2-methylprop-2-enoate Chemical compound CC(C)OC(=O)C(C)=C BOQSSGDQNWEFSX-UHFFFAOYSA-N 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 230000036344 tooth staining Effects 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- KVSKGMLNBAPGKH-UHFFFAOYSA-N tribromosalicylanilide Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=C(Br)C=C1 KVSKGMLNBAPGKH-UHFFFAOYSA-N 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the invention relates in general to anti-microbial film-forming compositions for placement in contact with biological surfaces, together with methods for their use.
- the invention relates more particularly to anti-microbial film- forming compositions that are placed at the interface between a biological surface and the surface of a prosthetic material in order to prevent the growth of microorganisms.
- BACKGROUND ART A wide variety of disinfectants, sanitizers, and sterilants is available for use in a clinical or surgical environment to destroy bacteria and prevent infections. Such compositions may be applied to the surface of the skin for the purpose of destroying microorganisms before they can be transferred to another surface during critical procedures.
- compositions used in the dental office for preparation of a tooth surface prior to placement of a resin-based restorative material generally do not contain agents that can control microbial growth.
- Cavity cleansers are an exception because they often contain water-soluble anti-microbial agents and detergents that are used to cleanse and disinfect the space created after removing carious enamel and/or dentin.
- Tooth conditioning agents are aqueous solutions of decalcifying agents (e.g. phosphoric acid). They are used to create surface irregularities prior to application of the restorative material (thus increasing mechanical retention). They are placed in contact with the tooth surface for a period of about 15 to 60 seconds, again, before being rinsed off with water.
- Tooth surface primers such as those used to create a bond between the natural dentin or enamel surface and a restorative material, typically contain compounds (such as unsaturated carboxylic acids) designed to bridge the interface between the biological and the restorative surfaces. Such compounds generally show little, if any, anti-microbial activity.
- compositions such as Alpha-DentTM Cavity Cleanser (Alphadental Products Co.; Chicago, IL) are used to cleanse the tooth structure prior to the placement of a restorative material.
- This composition contains about 2% by weight of chlorhexidine (the salts of which are water-soluble, cationic anti-microbial agents) in order to destroy any residual bacteria within a tooth preparation prior to the placement of a restorative material.
- chlorhexidine salts are acceptable for killing microorganisms in the oral cavity (these compounds have been thoroughly investigated for safety and efficacy), they are not well suited for placement at the interface between a biological surface and a resin-based restorative.
- Cationic compounds such as chlorhexidine, when allowed to reside on oral surfaces for an extended time, are known to facilitate the formation of tooth stains.
- cationic anti-microbial compounds tend to form salts with the adhesion-promoting carboxylate or phosphate moieties found in modem dentin and enamel bonding agents. Such salt formation leads to precipitation of insoluble adducts at the interface which at best, causes attenuation of the strength of adhesion promoters in many cases, simply renders them useless.
- the patent describes methods for treating tooth enamel or dentin involving etching or partial decalcification of said enamel or dentin, the improvement comprising the use of benzalkonium chloride as an anti-microbial agent, together with a suitable etching compound (preferably an aqueous solution of phosphoric acid) in a single-step application.
- a suitable etching compound preferably an aqueous solution of phosphoric acid
- the use of water-soluble cationic anti-microbial agents in a tooth etching composition at concentrations that would not interfere with the adhesion process would unlikely be able to prevent future microbial growth.
- compositions contains hydrogen peroxide or sodium hypochlorite. These compounds oxidatively destroy bacteria and debride root canals during root canal or endodontic therapy but at the same time are highly susceptible to reduction in activity in the presence of bodily fluids such as blood and saliva.
- a major drawback of the use of anti-microbial oxidizing agents is the reduction in bond strength observed with resin-based restorative materials placed in contact with a biological surface that has been oxidized. It is postulated that the increase in oxygen at the interface between the restorative material (or its attendant bonding agent) and the tooth preparation surface inhibits the polymerization reaction. The lower degree of polymerization at the interface thus causes a reduction in overall bond strength between the tooth surface and the restorative material.
- compositions and methods for preventing interfacial infections between the tooth surface and a restorative material Despite attempts to provide compositions and methods for preventing interfacial infections between the tooth surface and a restorative material, the incidence of recurrent caries still remains quite high. Other contributing factors may be poor marginal adaptation of the restoration due to shrinkage of the restorative material during polymerization and poor adhesion to the tooth surface. Infiltration at the restoration margins by oral fluids (together with oral microorganisms) under such circumstances can easily lead to secondary caries. Thus, in the absence of perfect marginal adaptation and/or a perfect bond between the tooth surface and the restorative material, there is a need for compositions that of exert an anti-microbial effect at the interface between the tooth surface and a resin-based restorative material for extended periods of time.
- Some film-forming compositions such as cosmetics, are placed on the body surface in order to enhance personal attractiveness, to moisturize the skin, and (more recently) to prevent the growth of microorganisms.
- Preservative agents such as methyl- and propylparabens, isochlorothiazolinones, phenolics and hydantoin compounds, are added to provide resistance to microbial growth in the package.
- An additional benefit is that anti-microbial compounds used to preserve a cosmetic preparation also provide a certain degree of germ killing on the surface of the skin when present as a part of the residual film (usually oil-based left behind after all or most of the volatile components of the composition such as water and fragrance have evaporated). Care must be taken not to include a level of preservative sufficient to cause irritation, inflammation, or sensitization of the skin.
- Cleaning compositions such as anti-microbial hand washes and deodorant soaps are also widely available. These compositions are not suitable for cleansing tooth surfaces prior to placing a restorative material due to the presence of high levels of both surfactants and water. Surfactants are irritating after extended contact and must be rinsed from the body surface. Cleansing surfactants also create a boundary layer at an interface between two materials, thus rendering them highly undesirable for use on a tooth surface preparation. High levels of water are also undesirable, due to the reduction in bond strength between the tooth surface and the resin-based restorative observed in the presence of excess moisture.
- compositions that can be placed directly onto a dental surface such as a tooth (and which may include the surrounding soft tissue) prepared for receiving a restorative material such as a filling or a dental prosthetic device such as a crown or brace, for the specific purpose of preventing microbial growth at the interface between the two surfaces (tooth and restorative or device).
- a dental surface such as a tooth (and which may include the surrounding soft tissue) prepared for receiving a restorative material such as a filling or a dental prosthetic device such as a crown or brace, for the specific purpose of preventing microbial growth at the interface between the two surfaces (tooth and restorative or device).
- a restorative material such as a filling or a dental prosthetic device such as a crown or brace
- One aspect of the present invention is directed to an anti-microbial composition that is applied to or contacted with a biological substrate.
- the application of the composition results in a residue of an anti-microbial agent being left on the surface which provides anti-microbial activity for an extended period of time.
- the compositions contain an anti-microbial agent and at least one volatile solvent.
- Film-forming agents also known as anti-microbial retention enhancing agents
- other agents that increase the penetration of the residue e.g., phosphoric acid, alpha hydroxy acids and chelating agents may also be present.
- the anti-microbial agent is non-cationic and water-insoluble.
- compositions are free of polishing agents, surfactants and in more preferred embodiments, water, to maximize the retention of the anti-microbial agent on the surface while reducing the time necessary for the residue to form.
- Preferred volatile solvents are organic solvents having fewer than 12 carbon atoms e.g., ethanol, isopropanol, acetone, ethyl acetate, diethyl ether, propionaldehyde and dichloromethane. More preferred solvents are ethanol and acetone.
- the compositions are simply applied to the biological substrate such as skin, keratinous tissue or dental tissue and allowed to dry. The residue of the anti-microbial agent left on the substrate inhibits microbial growth for a given period of time.
- the compositions are used in the course of various dental procedures, as dental primers. They are applied to or contacted with dental tissue (e.g., teeth and surrounding soft tissue) that has been treated by a clinician for purposes of applying a dental restorative compostion or a prosthetic device. What remains on the dental tissue is a residue or preferably, a film or layer of the anti-microbial agent.
- a film-forming polymer is included in the primer to enhance the even distribution of the anti-microbial agent over the dental surface.
- the anti-microbial agent also possesses analgesic and/or anti-inflammatory properties. Other agents possessing these properties may also be present.
- an organosilane is the sole solvent or one of the solvents included in the composition.
- Another aspect of the invention is directed to a dental adhesive composition containing a dental adhesive and a water-insoluble anti-microbial agent.
- the adhesive is preferably a bonding agent.
- the composition also contains a polymerizable solvent and a polymerization initiator.
- the present invention also provides methods of applying the adhesive composition to or contacting it with a dental surface prior to the application of the restorative composition or the prosthetic device.
- Another aspect of the present invention is directed to a method for bonding a dental restorative composition or prosthetic device to a dental surface.
- the method involves applying to or contacting the tooth with the dental primer, allowing a residue of the anti-microbial to form, applying to or contacting the tooth with the dental adhesive composition, allowing the dental adhesive and the anti-microbial agent to dry and then applying the restorative composition or device.
- Both the primer composition and the adhesive composition contain an anti-microbial agent, which may be the same or different, preferably the same.
- the anti-microbial compositions of the present invention are used to pre-treat or prime dental surfaces which are to be joined with restorative or reconstructive compositions such as fillings or dental or orthodontal prostheses or devices such as crowns, caps, dentures and braces.
- the compositions are not dentifices, mouthwashes or flosses.
- the compositions are said to "consist essentially of the solvent and the anti-microbial and thus exclude polishing agents, surfactants and more generally, any substance that would detract from the final result, namely leaving a residue or film of the anti-microbial agent on the dental surface or skin.
- compositions may further contain film forming agents and penetration enhancing agents such as phosphoric acid, hydrochloric acid, acetic acid and alpha hydroxyacids such as citric and tartaric acids. Chelating agents such as phosphonic acids and EDTA may be included as well.
- the compositions may be applied to the buccal cavity and the dental tissues by rinsing or directly (such as by way of applicator or finger). In other embodiments, the antimicrobial compositions are applied to external (i.e., non-oral) skin.
- any anti-microbial agent that is non-toxic, forms a residue on skin or dental tissue and provides anti-microbial activity thereon.
- examples include bisbiguanides such as chlorhexidine and phenolic compounds such as thymol, methyl salcylate, eucalyptol and menthol.
- the level of antimicrobial compound included in the composition is the minimum concentration that prevents the growth of microorganisms on the surface of and within a limited zone around the dental composition or device for an extended period of time.
- An extended period of time is herein defined as the amount of time during which the cured composition is in contact with the biological surface and during which the cured composition is exposed to potential colonization by one or more microorganisms.
- Preferred extended times include from a few days, to a few weeks to few months and even years.
- the anti-microbial agent is present in the composition in an amount of from about 0.05% to about 30%. Smaller amounts e.g., between about 0.05% and about 10% by total weight of the composition, are preferred.
- Preferred antimicrobials are water-insoluble (e.g., having a solubility in distilled water at 25 C of less than 1,000 ppm) and non-cationic.
- Classes of antimicrobials that are water-insoluble and non-cationic include halogenated diphenyl ethers (e.g., 2',4,4'-trichloro-2-hydroxy-diphenyl ether and 2,2'-dihydroxy-5,5'- dibromo-diphenyl ether); halogenated salicylanilides (e.g., 4', 5- dibromosalicylanilide, 3,4',5-trichlorosalicylanilide, 3,4',5-tribromosalicylanilide, 2,3,3',5-tetrachlorosalicylanilide, 3,3,3', 5-tetrachlorosalicylanilide, 3,5-dibromo-3'- trifluoromethyl salicylanilide, 5-n-octan
- the more preferred antimicrobial agents are substantially water-insoluble members of the halogenated diphenyl ether group and the phenolic group, in particular those compounds described in detail in U.S. Patents 4,894,220 and 5,800,803. See also U.S. Patents 5,665,333 and 5,686,064.
- the most preferred water-insoluble antimicrobial agent (herein defined as an antimicrobial compound having a solubility in distilled water at 25 °C of less than 1000 ppm) is triclosan (trade name Irgasan DP300).
- Triclosan (2,4,4'- trichloro-2'-hydroxydiphenyl ether, CAS No. 338034-5) is a broad spectrum antimicrobial with a molecular weight of 289.5, having very limited water solubility at physiological temperatures (20 ppm in distilled water at 20°C and 40 ppm in distilled water at 50°C).
- the safety of triclosan has been well established and its use in oral care products, primarily water-based toothpastes in which the triclosan, typically at a concentration of about 0.30 percent by weight, has been solubilized.
- the preferred amount of triclosan is from about 0.05% to about 30%; the more preferred amount is from about 0.05% to about 10%; and the most preferred range is from about 0.05% to about 1% by total weight of the composition.
- the solvents useful in the compositions of the present invention may be aqueous or substantially non-aqueous in nature.
- the solvent or solublizer provides a vehicle to deliver the anti-microbial agent to the dental tissue.
- the amount of solvent in the composition ranges from about 30% to about 99.99% by total weight of the composition, and preferably from about 95% to 99.99%. It is volatile in the common and everyday sense in that it evaporates readily at normal pressures and temperatures. Alternatively, it can be caused to partially or totally evaporate within a suitable period of time to allow the overall dental procedure to move along in relatively uninterrupted fashion.
- the composition is substantially non-aqueous (e.g., excluding water with the exception of water contained in commercial preparations of volatile organic solvents such as isopropanol).
- Preferred solvents are substantially non-aqueous in nature and include alcohols, keytones, aldehydes, esters, and ethers having fewer than 12 carbon atoms, and mixtures thereof.
- Examples include ethanol, acetone, propionaldehyde, ethyl acetate and diethyl ether.
- Other preferred non-aqueous solvents include organosilanes such as methacryloxypropyltrimethoxysilane.
- compositions of the present invention may also contain a film- forming polymeric material.
- a film- forming polymeric material The purpose of this ingredient is to enhance the retention of the anti-bacterial residue on the dental tissue for an extended period of time.
- This type of ingredient is well known in the art, and is disclosed, for example, in U.S. Patent 5,344,641 in terms of an antibacterial-enhancing agent.
- Preferred film- forming polymers include acrylates, mefhacrylates, celluloses, polycarboxylates, polyvinyl methyl ether/maleic copolymers, and combinations thereof.
- the composition is in the form of a dental primer.
- the purpose of the primer is to pre-treat a tooth that has been drilled or prepared to adapt it to receive a dental restorative composition or a dental prosthetic device.
- the anti-microbial agent also possesses analgesic and/or anti-inflammatory activity.
- Triclosan for examples possesses analgesic and anti-inflammatory properties. Otherwise, an analgesic and/or anti-inflammatory agent may be provided separately.
- the preferred solvent is an organosilane.
- the adhesive contains a water-insoluble anti-microbial agent and a bonding agent.
- the solvent is not necessary. Bonding agents may be light-curable or chemically cured. Examples includes urethane dimethacrylate, methacryloyloxyethyl maleate, triethyleneglycol dimethacrylate and bisphenol A-glycidyl methacrylate.
- the adhesive compositions contain a polymerizable solvent.
- the solvent is contained in the composition in an amount of from about 2% to about 90%, preferably from about 2% to about 30%, and more preferably from about 2% to about 15% by weight of the composition.
- Mefhacrylates are the preferred polymerizable non-aqueous solvents.
- mefhacrylates include methyl methacrylate, ethyl methacrylate, n-propyl methacrylate, isopropyl methacrylate, n-butyl methacrylate, isobutyl methacrylate, hydroxyethyl methacrylate, hydroxypropyl methacrylate, hydroxybutyl methacrylate, propylene glycol monomethacrylate, polyethylene glycol) monomethacrylate, isobomyl acrylate, isobomyl methacrylate, methoxyethoxyethyl methacrylate, ethoxyethyl methacrylate, tetrahydrofurfuryl methacrylate, acetoxyethyl methacrylate, ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, trimethylene glycol dimethacrylate, trimethylene glycol dimethacrylate, trimetholpropane trimethacrylate, 1,4-butane
- a polymerization initiator is also included with the solvent.
- examples include peroxy compounds such as benzoyl peroxide, cumene hydroperoxide and camphor qunione peroxide
- Another aspect of the present invention is directed to methods of pre- treating the buccal cavity and the teeth and surrounding soft tissue that are to receive a dental restorative composition or a dental prosthetic device.
- about 40 percent of fillings have recurrent caries. Bacteria penetrate gaps, pits, fissures, cracks and other imperfections in the tooth created at the interface of the tooth and the filling material. The roughness of the tooth-filling interface also contributes to bacterial growth. The same phenomenon occurs in the case of caps or crowns.
- a preferred embodiment of this aspect entails a method for priming a dental surface to receive a dental reconstructive composition or prosthetic device.
- the tooth may have been drilled or otherwise prepared to have its surface altered to cleanse the cavity and better adapt the tooth to receive the composition or device.
- a dental primer is applied to the tooth or teeth.
- the primer contains a first anti-microbial agent and a volatile solvent in which the agent is soluble.
- a residue of the agent is left on the dental surface.
- the purpose of the primer is to make the tooth more receptive to the bonding agent by reducing the surface tension so that the bonding agent penetrates the crevices in the tooth.
- the solvent is allowed to evaporate.
- the dental adhesive composition is applied to the primed dental surface.
- the adhesive composition contains a bonding agent and a second anti-microbial agent, wherein the first and second anti-microbial agents may be the same or different. It is preferred that they are the same.
- the adhesive composition is allowed to harden thus leaving a residue of the antimicrobial agent and the bonding agent on the dental surface.
- the dental restorative composition or dental prosthetic device is then applied to the dental surface.
- the restorative composition or prosthetic device adheres to said dental surface and the anti-microbial agent inhibits microbial growth where composition or device forms an interface with the dental surface.
- the dental restorative composition is a filling or material used to replace missing teeth.
- the dental prosthetic devices covers a tooth, and in some cases, the surrounding soft tissue as well. Examples of devices include crowns or caps, braces, retainers and dentures.
- a dental restorative composition can be applied following treatment with only the primer.
- a dental prosthetic device is applied following treatment with only the adhesive composition.
- Non carious teeth were extracted from an individual suffering from periodontal disease and stored in distilled water for 24 hours.' To determine the disinfective properties of the above solutions the teeth were not sterilized prior to use. The teeth were washed with 10 ml of distilled water and incubated in stimulated saliva for 5 minutes. The teeth were then air-dried and anti-microbial solutions (Solutions 1A and IB) were painted onto the surface of the teeth using a dental office brush, such as the brush sold under the name Benda BrushTM by Centrix (CT). . The teeth were then dried with a compressed air dental syringe for one minute in order to evaporate all of the alcohol.
- a dental office brush such as the brush sold under the name Benda BrushTM by Centrix (CT).
- the teeth were placed onto Petri dishes containing a standard aqueous trypticase soy agar medium supplemented with sucrose. Control teeth were treated in the same fashion with water and a standard commercial cavity vamish sold under the name CopaliteTM by Cooley & Cooley of Houston, Texas.
- the teeth to be tested were extracted and stored in distilled water for 24 hours.
- the teeth were then removed and rinsed 3 times with 10 ml distilled water.
- the teeth were dried using a compressed air dental syringe, following with either 0J ml of water, CopaliteTM, Solution IA or Solution IB were painted onto the surface of the teeth using the Bend-A-BrushTM dental office brush.
- the teeth were then dried with a compressed air dental syringe for one minute in order to evaporate all of the alcohol, water, or CopaliteTM solvent.
- the teeth were then placed onto standard aqueous trypticase soy agar supplemented with sucrose and inoculated with 0.25 ml of human saliva. The saliva was collected from an individual who, for the purposes of this test, did not brush for 12 hours.
- EXAMPLE 3 Single-component, anti-microbial dental primer and adhesive compositions were prepared in accordance with this invention by dissolving triclosan in the same solvent used to deliver the adhesion-promoting agents to the tooth surface.
- the compositions shown in Table 4 are all visible light-cured, anti-microbial dental priming and/or bonding agents.
- the invention is useful in preventing bacterial infection at the interface of a biological system and a medical device.
- the invention is of use in preventing infection at the boundary between and around a dental restorative composition or dental reconstructive prosthesis (e.g., a crown or filling) and tooth enamel, dentin, root or gum tissue.
- the invention is useful in the adhesion of a dental reconstructive prosthesis to a dental surface under conditions that inhibit microbial growth at the interface between the prosthesis and the dental surface.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10702698P | 1998-11-04 | 1998-11-04 | |
| US107026P | 1998-11-04 | ||
| PCT/US1999/026073 WO2000025697A1 (en) | 1998-11-04 | 1999-11-04 | Antimicrobial compositions that protect skin and dental tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1126792A1 true EP1126792A1 (de) | 2001-08-29 |
Family
ID=22314475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99961586A Withdrawn EP1126792A1 (de) | 1998-11-04 | 1999-11-04 | Antimikrobische zusammensetzungen zum beschüutzen von haut und zahngewebe |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1126792A1 (de) |
| AU (1) | AU1813300A (de) |
| WO (1) | WO2000025697A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10813849B2 (en) * | 2015-02-05 | 2020-10-27 | University Of Maryland, Baltimore | Rechargeable calcium phosphate-containing dental materials |
| US10004673B1 (en) | 2017-02-08 | 2018-06-26 | L'oreal | Hair treatment composition comprising Michael addition product and methods for treating hair |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888491A (en) * | 1993-12-06 | 1999-03-30 | Minnesota Mining And Manufacturing Company | Optionally crosslinkable coatings, compositions and methods of use |
| US5607663A (en) * | 1994-12-01 | 1997-03-04 | Minnesota Mining And Manufacturing Company | Hydrocarbyl containing coatings, compositions and methods of use |
| US5662887A (en) * | 1994-12-01 | 1997-09-02 | Minnesota Mining And Manufacturing Company | Fluorocarbon containing coatings, compositions and methods of use |
-
1999
- 1999-11-04 WO PCT/US1999/026073 patent/WO2000025697A1/en not_active Ceased
- 1999-11-04 AU AU18133/00A patent/AU1813300A/en not_active Abandoned
- 1999-11-04 EP EP99961586A patent/EP1126792A1/de not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0025697A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000025697A1 (en) | 2000-05-11 |
| AU1813300A (en) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU756369B2 (en) | Antimicrobial denture adhesive composition | |
| Gürgan et al. | Effect of disinfectant application methods on the bond strength of composite to dentin | |
| Turkun et al. | Is an antibacterial adhesive system more effective than cavity disinfectants? | |
| US20080031831A1 (en) | Oral anti-calculus compositions and methods of use thereof | |
| JP2026509579A (ja) | カテコール系化合物を使用した歯の再石灰化 | |
| WO2011050369A1 (en) | Treatment varnish compositions for teeth surfaces | |
| US20100173267A1 (en) | Method for producing restorative tooth preparation and treatment compositions and product | |
| Kazemi et al. | Permeability changes of dentine treated with titanium tetrafluoride | |
| JP3710135B2 (ja) | 歯石溶解剤 | |
| JPS59225109A (ja) | 口腔内用組成物 | |
| Maiya | Applications of ozone in dentistry | |
| WO2000025697A1 (en) | Antimicrobial compositions that protect skin and dental tissue | |
| JP2021091619A (ja) | 歯科口腔用組成物および細菌感染治療用組成物 | |
| WO2009106972A2 (en) | Dental composition for desensitizing, disinfecting and protecting exposed dentine | |
| Darabi et al. | Effect of chlorhexidine on microleakage of composite | |
| JP4582572B2 (ja) | 根管洗浄液 | |
| JPH11240816A (ja) | 歯牙被覆用組成物 | |
| JP2866393B2 (ja) | 歯垢蓄積抑制口腔用組成物 | |
| US10821058B2 (en) | Conditioning composition | |
| Karuna et al. | CAVITY DISINFECTANTS IN RESTORATIVE DENTISTRY-JOURNEY TO DATE. | |
| Heta et al. | Application of chlorhexidine and its effect on hybrid layers: A review of the literature | |
| JP4588348B2 (ja) | 歯石及びウ蝕部除去剤 | |
| JP2005139201A (ja) | 歯石及びウ蝕部溶解剤 | |
| Shayegan et al. | Impact of Five Cleansing Agents on Microleakage in Class V Restorations: A Comparative In Vitro Study | |
| US20110301240A1 (en) | Conditioning composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20010427 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20051107 |